London-listed drugmaker AstraZeneca said its plan to invest 450 million pounds ($576.7 million) in Britain for vaccine ...

AstraZeneca AZN0.05%increase; green up pointing triangle said it plans to pump $2 billion in new investment into the U.S., ...

英国剑桥 - AstraZeneca PLC (LSE/STO/Nasdaq: AZN) 宣布在美国进行重大扩张，投资35亿美元用于扩大其研究和制造能力。这项投资计划将在2026年底前完成，预计将创造超过一千个高技能就业岗位，为经济增长做出贡献。 这家生物制药公司的投资将包括在马萨诸塞州剑桥市肯德尔广场建立一个新的最先进的研发中心，以及在马里兰州建立一个下一代生物制品制造设施。其他发展还包括在美国 ...

AstraZeneca plans a new investment of $2 billion in the U.S., one of the first major foreign companies to shift spending to ...

LONDON, Nov 12 (Reuters) - London-listed drugmaker AstraZeneca (AZN.L), opens new tab said its plan to invest 450 million ...

AstraZeneca’s earnings were boosted by its oncology, cardiovascular, respiratory and immunology (R&I), and rare disease ...

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

LONDON — AstraZeneca said Tuesday it has had to resubmit a closely watched medicine for U.S. approval in a different form of ...

The U.K. drugmaker also announced plans to drop another $2 billion on expanding its R&D and manufacturing footprint in the ...

Net Debt to EBITDA Ratio: 1.8 times. Full Year Guidance Upgrade (2024): Total revenue and core EPS expected to grow by high ...

AstraZeneca's Q3 sales rose 18% YoY to $13.6 billion Adjusted EPADS hit $1.04, exceeding expectations. U.S. investment of ...